Pdp (833)
Sildenafil
Product Images NDC 45865-833
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 45865-833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-10 (Sildenafil Fig 10)
Figure-11 (Sildenafil Fig 11)
Fig-12 (Sildenafil Fig 12)
Fig-6 (Sildenafil Fig 6)
Fig-8 (Sildenafil Fig 8)
The text appears to be a chart of different drugs and their recommended dosages with some additional information on interactions and fold change with 90% CI. It also includes a note on the lack of benefit when sildenafil is added to bosentan therapy and the effect of ritonavir on sildenafil PK.*
Figure-9 (Sildenafil Fig 9)
Figure-7 (Sildenafil Figure 7)
This text provides information on drug interactions and recommended dose adjustments. It includes specific drugs such as Atorvastatin, Astromycin, Bosentan, Cimetidine, Evermyel:f and Saquinavir, and outlines whether a dose adjustment is necessary or not. Oral contraceptives are also mentioned, and although no dose adjustment is recommended, co-administration is not recommended. The text displays a chart with a vertical line at x=1 and a note stating that no benefit on exercise capacity is observed when sildenafil is added to bosentan therapy.*
Str (Sildenafil Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
